Covered recipient · General Payments record
HOWARD W HAUPTMAN
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2024
$22,896.21
- Reported across 371 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $408.72 | 16 |
| Education | $99.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $99.00 | 1 |
| ABBVIE INC. | $97.89 | 4 |
| Amgen Inc. | $68.21 | 3 |
| UCB, Inc. | $61.03 | 2 |
| Aurinia Pharma U.S., Inc. | $29.65 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $28.83 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $28.68 | 1 |
| Lilly USA, LLC | $25.17 | 1 |
| Kiniksa Pharmaceuticals International, plc | $24.17 | 1 |
| GENZYME CORPORATION | $23.83 | 1 |
| PFIZER INC. | $21.26 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.14 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103892123 | CMS |
| ABBVIE INC. | $18.71 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103892125 | CMS |
| ABBVIE INC. | $25.31 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103892127 | CMS |
| ABBVIE INC. | $34.73 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103892129 | CMS |
| Amgen Inc. | $14.06 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111596138 | CMS |
| Amgen Inc. | $24.56 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111596134 | CMS |
| Amgen Inc. | $29.59 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111596136 | CMS |
| Aurinia Pharma U.S., Inc. | $29.65 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150681753 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $28.68 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118192658 | CMS |
| GENZYME CORPORATION | $23.83 | 10/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139581200 | CMS |
| Janssen Biotech, Inc. | $99.00 | 08/16/2024 | Education | Undisputed | 01/23/2026 | 1078707737 | CMS |
| Kiniksa Pharmaceuticals International, plc | $24.17 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154860578 | CMS |
| Lilly USA, LLC | $25.17 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135006703 | CMS |
| Novartis Pharmaceuticals Corporation | $28.83 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086958689 | CMS |
| PFIZER INC. | $21.26 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131406286 | CMS |
| UCB, Inc. | $27.47 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143204075 | CMS |
| UCB, Inc. | $33.56 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143204080 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.